Regenxbio Inc (RGNX)

Debt-to-equity ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 311,742 363,100 405,855 465,139 516,195 563,824 630,519 689,669 764,298 461,414 507,245 554,504 377,753 415,660 397,861 420,152 450,197 468,395 494,592 487,053
Debt-to-equity ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2023 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $311,742K
= 0.00

Regenxbio Inc has consistently maintained a debt-to-equity ratio of 0.00 across all quarters in the provided dataset, indicating that the company has not used any debt to finance its operations relative to its equity. This suggests that Regenxbio relies primarily on equity financing, which may indicate a lower level of financial risk and potential for financial distress. However, it is important to note that a zero debt-to-equity ratio may also imply missed opportunities for leveraging debt to potentially enhance returns for shareholders. Overall, a consistent zero debt-to-equity ratio reflects Regenxbio's conservative capital structure and financial stability.


Peer comparison

Dec 31, 2023